Many antibody tests have been developed since the pandemic started, but very few are designed to specifically detect the Sars-CoV-2 neutralizing antibodies which prevent infection. Based on protein ...

Undertaking a study of proteins found in the complement system, an important part of the immune system, of patients with long COVID, researchers have identified a blood protein ‘signature’ that may ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

In the last five years, neuronal pentraxins have emerged as potential markers of synaptic loss. In the case of NPTX2, researchers may now be able to explain why. In the March 29 Science Translational ...

Protein degradation is a critical regulatory mechanism for controlling protein levels. However, proteome-wide degradation measurements remain technically challenging, and even in the well-studied E.